These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1986101)

  • 1. Immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in 3- to 17-month-old infants with sickle cell diseases.
    Marcinak JF; Frank AL; Labotka RL; Rao S; Drawhorn L; Dampier C; Frisone LR; Yogev R; McVerry P
    J Pediatr; 1991 Jan; 118(1):69-71. PubMed ID: 1986101
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with sickle cell disease.
    Rubin LG; Voulalas D; Carmody L
    Am J Dis Child; 1992 Mar; 146(3):340-2. PubMed ID: 1543182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in vaccinated children who developed Haemophilus disease.
    Weinberg GA; Murphy TV; Granoff DM
    Pediatrics; 1990 Oct; 86(4):617-20. PubMed ID: 2216629
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children with sickle hemoglobinopathy or malignancies, and after systemic Haemophilus influenzae type b infection.
    Kaplan SL; Duckett T; Mahoney DH; Kennedy LL; Dukes CM; Schaffer DM; Mason EO
    J Pediatr; 1992 Mar; 120(3):367-70. PubMed ID: 1538281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
    Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
    Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children with conditions associated with impaired antibody responses to type b polysaccharide vaccine.
    Weinberg GA; Granoff DM
    Pediatrics; 1990 Apr; 85(4 Pt 2):654-61. PubMed ID: 2179856
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with congenital asplenia.
    Webber SA; Sandor GG; Patterson MW; Mitchell LA; Scheifele D; Ochnio JJ; McVerry PH
    J Infect Dis; 1993 May; 167(5):1210-2. PubMed ID: 8486956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine.
    Marchant CD; Band E; Froeschle JE; McVerry PH
    Pediatr Infect Dis J; 1989 Aug; 8(8):508-11. PubMed ID: 2788860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines.
    Granoff DM; Holmes SJ
    Vaccine; 1991 Jun; 9 Suppl():S30-4; discussion S42-3. PubMed ID: 1891954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of children to booster immunization with their primary conjugate Haemophilus influenzae type B vaccine or with polyribosylribitol phosphate conjugated with diphtheria toxoid.
    Decker MD; Edwards KM; Bradley R; Palmer P
    J Pediatr; 1993 Mar; 122(3):410-3. PubMed ID: 8441096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the combined administration of Haemophilus influenzae type B--diphtheria toxoid conjugate vaccine (PRP-D) and DTP.
    Gordon LK
    Dev Biol Stand; 1986; 65():113-21. PubMed ID: 3549393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine (PRP-D) in infants.
    Lepow ML; Barkin RM; Berkowitz CD; Brunell PA; James D; Meier K; Ward J; Zahradnik JM; Samuelson J; McVerry PH
    J Infect Dis; 1987 Oct; 156(4):591-6. PubMed ID: 3497990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Finnish efficacy trials with Haemophilus influenzae type b vaccines.
    Eskola J; Peltola H; Käyhty H; Takala AK; Mäkelä PH
    J Infect Dis; 1992 Jun; 165 Suppl 1():S137-8. PubMed ID: 1588148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the Haemophilus influenzae type b conjugate vaccine PRP-D.
    Robbins JB; Schneerson R
    N Engl J Med; 1990 Nov; 323(20):1415-6. PubMed ID: 2233910
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunization of young infants with sickle cell disease with a Haemophilus influenzae type b saccharide-diphtheria CRM197 protein conjugate vaccine.
    Gigliotti F; Feldman S; Wang WC; Day SW; Brunson G
    J Pediatr; 1989 Jun; 114(6):1006-10. PubMed ID: 2786061
    [No Abstract]   [Full Text] [Related]  

  • 17. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines.
    Käyhty H; Eskola J; Peltola H; Saarinen L; Mäkelä PH
    J Infect Dis; 1992 Jun; 165 Suppl 1():S165-6. PubMed ID: 1588156
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity of Haemophilus influenzae type b polysaccharide--diphtheria toxoid conjugate vaccine in adults.
    Granoff DM; Boies EG; Munson RS
    J Pediatr; 1984 Jul; 105(1):22-7. PubMed ID: 6610736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
    Eskola J; Peltola H; Takala AK; Käyhty H; Hakulinen M; Karanko V; Kela E; Rekola P; Rönnberg PR; Samuelson JS
    N Engl J Med; 1987 Sep; 317(12):717-22. PubMed ID: 3306379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1- to 6-month-old infants.
    Madore DV; Johnson CL; Phipps DC; Popejoy LA; Eby R; Smith DH
    Pediatrics; 1990 Mar; 85(3):331-7. PubMed ID: 2304786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.